These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 675585)

  • 21. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
    Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to thrombin directed against both of its cryptic exosites.
    Mollica L; Preston RJ; Chion AC; Lees SJ; Collins P; Lewis S; Lane DA
    Br J Haematol; 2006 Feb; 132(4):487-93. PubMed ID: 16412021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization of heparin by prothrombin activation products.
    Pieters J; Franssen J; Visch C; Lindhout T
    Thromb Res; 1987 Mar; 45(5):573-80. PubMed ID: 3590093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method.
    Callas DD; Fareed J
    Thromb Res; 1996 Sep; 83(6):463-8. PubMed ID: 8885140
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system.
    Takeda Y
    J Lab Clin Med; 1970 Mar; 75(3):355-81. PubMed ID: 4984660
    [No Abstract]   [Full Text] [Related]  

  • 26. [Physiological inhibitors of thrombin and thrombin synthesis].
    Schröer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(2):212-22. PubMed ID: 4122964
    [No Abstract]   [Full Text] [Related]  

  • 27. The sensitivity of human and bovine thrombin to heparin in plasma.
    Denson KW
    Thromb Res; 1981 Aug; 23(3):207-13. PubMed ID: 7302926
    [No Abstract]   [Full Text] [Related]  

  • 28. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
    Oshima G; Nagai T; Nagasawa K
    Thromb Res; 1984 Sep; 35(6):601-11. PubMed ID: 6209818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High affinity binding of thrombin to platelets. Inhibition by tetranitromethane and heparin.
    Workman EF; White GC; Lundblad RL
    Biochem Biophys Res Commun; 1977 Apr; 75(4):925-32. PubMed ID: 861034
    [No Abstract]   [Full Text] [Related]  

  • 33. The catalysis by heparin of the reaction between thrombin and antithrombin.
    Evington JR; Feldman PA; Luscombe M; Holbrook JJ
    Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The action of thrombin on blood clotting factor V: conversion of factor V to a prothrombin-binding protein.
    Esmon CT; Owen WG; Duiguid DL; Jackson CM
    Biochim Biophys Acta; 1973 May; 310(1):289-94. PubMed ID: 4736336
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
    Ofosu FA; Fareed J; Smith LM; Anvari N; Hoppensteadt D; Blajchman MA
    Eur J Biochem; 1992 Jan; 203(1-2):121-5. PubMed ID: 1730217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.
    Petersen LC; Jørgensen M
    Biochem J; 1983 Apr; 211(1):91-7. PubMed ID: 6870832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of a catalytic role of heparin in anticoagulation reactions.
    Gitel SN
    Adv Exp Med Biol; 1975; 52():243-7. PubMed ID: 1124699
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma protein binding properties to immobilized heparin and heparin-albumin conjugate.
    Mirow N; Zimmermann B; Maleszka A; Knobl H; Tenderich G; Koerfer R; Herberg FW
    Artif Organs; 2007 Jun; 31(6):466-71. PubMed ID: 17537059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.